DFB Pharmaceuticals, a private investment and development group established in 1990, focuses on creating value in healthcare and life science operating businesses through strategic acquisitions, product development, and operational excellence.
The company's innovative approach includes a clinical stage oncology company targeting cancer therapies directly into solid tumors, harnessing plant cell fermentation technology for plant-derived pharmaceuticals, and distributing commercial healthcare products globally.
Generated from the website